SRC and cancer: In agreement with this hypothesis, our results show that even when active Csk is expressed in the Chk-deficient DLD1 colorectal cancer cells, Src is over-activated, suggesting that the co-expressed Csk cannot effectively constrain the activity of Src in these cancer cells.